[1]中心静脉通路上海协作组,上海市抗癌协会实体肿瘤聚焦诊疗专委会血管通路专家委员会.完全植入式输液港上海专家共识(2019) [J].介入放射学杂志,2019,28(12):1123-1128.
 Shanghai Cooperation Group on Central Venous Access,Expert Committee on Vascular Access,Committee of Experts on Focused Diagnosis and Treatment of Solid Tumors,et al.Consensus of Shanghai experts on totally implantable access port(2019)[J].journal interventional radiology,2019,28(12):1123-1128.







Consensus of Shanghai experts on totally implantable access port(2019)
Shanghai Cooperation Group on Central Venous Access; Expert Committee on Vascular Access Committee of Experts on Focused Diagnosis and Treatment of Solid Tumors Shanghai Anti-Cancer Association
【关键词】 完全植入式输液港 植入术 维护 标准并发症
【摘要】 完全植入式输液港(TIAP),主要用于需要中心静脉输液治疗及外周血管条件差的患者。由于具有携带方便、维护周期长、并发症少、患者生活质量高等优点,TIAP近年来逐步被患者和医师、护士所接受和推广。目前国内开展TIAP植入手术的医务人员包括外科、内科、放射科、麻醉科、血管通路护士等,大多属于兼职行TIAP植入,对于TIAP标准化操作流程和并发症诊断与处理理念和认识参差不齐,使得不同医疗单位植入和使用过程中的并发症发生率及处理方法各不相同。基于此,有必要对2015年发布的《完全植入式输液港上海专家共识》进行更新,在继续强调规范化植入与维护的同时,探索相关并发症的诊治流程。


[1] 中心静脉通路上海协作组.完全植入式输液港上海专家共识[J]. 介入放射学杂志, 2015, 24: 1029- 1033.
[2] Dawson, RB. PICC Zone Insertion MethodTM(ZIMTM):a systematic approach to determine the ideal insertion site for PICCs in the upper arm[J]. J Assoc Vasc Access, 2011, 16: 156- 165.
[3] Nifong TP, McDevitt TJ. The effect of catheter to vein ratio on blood flow rates in a simulated model of peripherally inserted central venous catheters[J]. Chest, 2011, 140: 48- 53.
[4] Sharp R, Cummings M, Fielder A, et al. The catheter to vein ratio and rates of symptomatic venous thromboembolism in patients with a peripherally inserted central catheter(PICC): a prospective cohort study[J]. Int J Nurs Stud, 2015, 52: 677- 685.
[5] Saugel B, Scheeren TWL, Teboul JL. Ultrasound- guided central venous catheter placement: a structured review and recommen- dations for clinical practice[J]. Crit Care, 2017, 21: 225.
[6] Biffi R, Pozzi S, Bonomo G, et al. Cost effectiveness of different central venous approaches for port placement and use in adult oncology patients: evidence from a randomized three- arm trial[J]. Ann Surg Oncol, 2014, 21: 3725- 3731.
[7] Sousa B, Furlanetto J, Hutka M, et al. Central venous access in oncology: ESMO Clinical Practice Guidelines[J]. Ann Oncol, 2015, 26(Suppl 5): V152- V168.
[8] 简志祥. 外科感染防治部分指南解读[J]. 中国实用外科杂志,2016, 36:185- 187.
[9] 马 坚,胡必杰. 导管相关性血流感染的预防控制指南2011年版本[J]. 中华医院感染学杂志, 2011, 21: 2648- 2650.
[10] 陶一明,王志明. 《外科手术部位感染的预防指南(2017)》更新解读[J]. 中国普通外科杂志, 2017, 26: 821- 824.
[11] Mahlon MA, Yoon HC. CT angiography of the superior vena cava: normative values and implications for central venous catheter position[J]. J Vasc Interv Radiol, 2007, 18: 1106- 1110.
[12] Song YG, Byun JH, Hwang SY, et al. Use of vertebral body units to locate the cavoatrial junction for optimum central venous catheter tip positioning[J]. Br J Anaesth, 2015, 115: 252- 257.
[13] Aslamy Z, Dewald CL, Heffner JE. MRI of central venous anatomy[J]. Chest, 1998, 114: 820- 826.
[14] Walker G, Chan RJ, Alexandrou E, et al. Effectiveness of electrocardiographic guidance in CVAD tip placement[J]. Br J Nurs, 2015, 24:S4- S12.
[15] Infusion Nurses Society. Infusion Therapy Standards of 2016: policies and procedures for infusion therapy[S]. Norwood: Infusion Nurses Society, 2016.
[16] Queensland GHD. Totally implantable central venous access ports guideline[EB/OL]. https://www.health.qld.gov.au/__data/assets/pdf_file/0030/444486/icare- port- guideline.pdf,2018- 06- 10 3- 28.
[17] 张黎露, 张静文, 周文珊, 等. 癌症病人常用中心静脉导管临床照护指引[J]. 肿瘤护理杂志, 2013, 13: 15- 37.
[18] 中华人民共和国国家卫生和计划生育委员会. 中华人民共和国卫生行业标准—静脉治疗护理技术操作规范WS/T433[S]. 2013.
[19] 陈海燕,钱培芬. 静脉血管通路护理实践指南[M]. 上海: 复旦大学出版社, 2016.
[20] 徐 波, 耿翠芝. 肿瘤治疗血管通道安全指南[M]. 北京:中国协和医科大学出版社, 2015.
[21] 蔡 虻,高凤莉. 导管相关感染防控最佳护理实践专家共识[M]. 北京: 人民卫生出版社, 2018.
[22] 胡 明, 褚 珺,陈其民, 等. 婴幼儿超声辅助下颈内静脉穿刺植入完全植入式静脉输液港评价[J].介入放射学杂志, 2017, 26:684- 687.
[23] Perin G, Scarpa MG. Defining central venous line position in children: tips for the tip[J]. J Vasc Access, 2015, 16: 77- 86.
[24] Justo JA, Bookstaver PB. Antibiotic lock therapy: review of technique and logistical challenges[J]. Infect Drug Resist, 2014, 7: 343- 363.
[25] Mitchell MD, Agarwal R, Hecht TE. Nonpharmacologic interventions for prevention of catheter- related thrombosis: a systematic review[J]. J Crit Care, 2013, 28: 316.e9- 316.e16.
[26] Rajasekhar A, Streiff MB. How I treat central venous access device- related upper extremity deep vein thrombosis[J]. Blood, 2017, 129: 2727- 2736.
[27] Verso M, Agnelli G. Venous thromboembolism associated with long- term use of central venous catheters in cancer patients[J]. J Clin Oncol, 2003, 21: 3665- 3675.
[28] Khorana AA, Noble S, Lee AYY, et al. Role of direct oral anticoagulants in the treatment of cancer- associated venous thromboembolism: guidance from the SSC of the ISTH[J]. J Thromb Haemost, 2018, 16: 1891- 1894.
[29] Streiff MB, Holmstrom B, Ashrani A, et al. Cancer- Associated Venous Thromboembolic Disease, Version 1. 2015[J]. J Natl Compr Canc Netw, 2015, 13:1079- 1095.
[30] Brismar B, Hardstedt C, Jacobson S. Diagnosis of thrombosis by catheter phlebography after prolonged central venous catheterization[J]. Ann Surg, 1981, 194: 779- 783.
[31] Rockoff MA, Gang DL, Vacanti JP. Fatal pulmonary embolism following removal of a central venous catheter[J]. J Pediatr Surg, 1984, 19: 307- 309.
[32] Gray RJ, Levitin A, Buck D, et al. Percutaneous fibrin sheath stripping versus transcatheter urokinase infusion for malfunctioning well- positioned tunneled central venous dialysis catheters: a prospective, randomized trial[J]. J Vasc Interv Radiol, 2000, 11: 1121- 1129.
[33] Massmann A, Jagoda P, Kranzhoefer N, et al. Local low- dose thrombolysis for safe and effective treatment of venous port- catheter thrombosis[J]. Ann Surg Oncol, 2015, 22: 1593- 1597.
[34] Whigham CJ, Lindsey JI, Goodman CJ, et al. Venous port salvage utilizing low dose tPA[J]. Cardiovasc Intervent Radiol, 2002, 25: 513- 516.
[35] Meers C, Toffelmire EB. Urokinase efficacy in the restoration of hemodialysis catheter function[J]. J CANNT, 1998, 8: 17- 19.
[36] Chang DH, Mammadov K, Hickethier T, et al. Fibrin sheaths in central venous port catheters: treatment with low- dose, single injection of urokinase on an outpatient basis[J]. Ther Clin Risk Manag, 2017, 13: 111- 115.
[37] Gonda SJ, Li R. Principles of subcutaneous port placement[J]. Tech Vasc Interv Radiol, 2011, 14: 198- 203.
[38] Duszak R Jr, Haskal ZJ, Thomas- Hawkins C, et al. Replacement of failing tunneled hemodialysis catheters through pre- existing subcutaneous tunnels: a comparison of catheter function and infection rates for de novo placements and over- the- wire exchanges[J]. J Vasc Interv Radiol, 1998, 9: 321- 327.
[39] Sotiriadis C, Hajdu SD, Degrauwe S, et al. A novel technique using a protection filter during fibrin sheath removal for implanted venous access device dysfunction[J]. Cardiovasc Intervent Radiol, 2016, 39: 1209- 1212.
[40] Heye S, Maleux G, Goossens GA, et al. Feasibility and safety of endovascular stripping of totally implantable venous access devices[J]. Cardiovasc Intervent Radiol, 2012, 35: 607- 612.
[41] Knutstad K, Hager B, Hauser M. Radiologic diagnosis and management of complications related to central venous access[J]. Acta radiol, 2003, 44: 508- 516.
[42] Hinke DH, Zandt- Stastny DA, Goodman LR, et al. Pinch- off syndrome: a complication of implantable subclavian venous access devices[J]. Radiology, 1990, 177: 353- 356.
[43] Ko SY, Park SC, Hwang JK, et al., Spontaneous fracture and migration of catheter of a totally implantable venous access port via internal jugular vein: a case report[J]. J Cardiothorac Surg, 2016,11: 50.
[44] Surov A, Wienke A, Carter JM, et al. Intravascular embolization of venous catheter: causes, clinical signs, and management: a systematic review[J]. JPEN J Parenter Enteral Nutr, 2009, 33: 677- 685.
[45] Mirza B, Vanek VW, Kupensky DT. Pinch- off syndrome: case report and collective review of the literature[J]. Am Surg, 2004, 70: 635- 644.
[46] Karam AR, Hourani MH, Al- Kutoubi AO. Catheter fracture and migration into the coronary sinus: an unusual migration site: case report and review[J]. Clin Imaging, 2009, 33: 140- 143.
[47] Pignataro BS, Nishinari K, Wolosker N, et al. Fracture and migration into the coronary sinus of a totally implantable catheter introduced via the right internal jugular vein[J]. BMJ Case Rep, 2014. pii: bcr2014207276.
[48] Arnould MA, Blanchard D. Catheter migration after fracture is not always in right cavities[J]. Cardiovasc Interv Ther, 2013, 28: 119- 122.
[49] 许立超, 李文涛, 陆箴琦. 全程管理是中心静脉通路安全保障[J]. 介入放射学杂志, 2017, 26:673- 675.


 Shanghai Cooperation Group on central venous access.Shanghai expert consensus on fully implantable infusion port[J].journal interventional radiology,2015,(12):1029.
[9]仇晓霞,金光鑫,郭 艳,等.手臂和呼吸运动对上臂完全植入式输液港导管尖端位置的影响[J].介入放射学杂志,2022,31(12):1155.
 QIU Xiaoxia,JIN Guangxin,GUO Yan,et al.The influence of arm and breathing movements on the catheter tip position of totally implantable access port implanted via upper arm approach[J].journal interventional radiology,2022,31(12):1155.
[10]潘天帆,高 峰,任冬青,等.完全植入式输液港植入术后导管头端异位介入复位6例[J].介入放射学杂志,2023,32(3):251.
 PAN Tianfan,GAO Feng,REN Dongqing,et al.Interventional restoration for malposition of catheter tip after the placement of totally implantable access port: preliminary results in 6 cases.[J].journal interventional radiology,2023,32(12):251.


 (收稿日期:2019- 08- 06)
(本文编辑:边 佶)
更新日期/Last Update: 2019-12-27